Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|17|4|338-350

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.17, Iss.4, 2017-01, pp. : 338-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Bemiparin Sodium versus Unfractionated Heparin and Oral Anticoagulants in the Acute and Long-Term Treatment of Deep Vein Thrombosis

By Gómez-Outes Antonio  

PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. : 81-92

Adis International

Access to resources Recommend Favorite

Treatment options for deep vein thrombosis

By Squizzato Alessandro   Dentali Francesco   Ageno Walter  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1069-1075

Informa Healthcare

Access to resources Recommend Favorite

New Anticoagulants for the Prevention of Deep Venous Thrombosis: Time to Consider Cost Effectiveness?

By Apostolakis Stavros   Shantsila Eduard   Lip Gregory Y.H.  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 793-795

Adis International

Access to resources Recommend Favorite

Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients?

By Ponziani Francesca Romana   Zocco Maria Assunta   Tortora Annalisa   Gasbarrini Antonio  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1479-1487

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide: Deep vein thrombosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1260, 2009-01 ,pp. : 29-29

Adis International

Access to resources Recommend Favorite